CervoMed Inc. Announces Board Changes and Officer Appointments
Ticker: CRVO · Form: 8-K · Filed: Oct 29, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Oct 29, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $7 |
| Sentiment | neutral |
Sentiment: neutral
Topics: board-changes, officer-appointment, compensation
TL;DR
CervoMed board shakeup, new officers appointed, and compensation details disclosed.
AI Summary
CervoMed Inc. announced on October 27, 2025, a change in its board of directors, with the election of new directors and the appointment of certain officers. The company also disclosed compensatory arrangements for its officers and provided a Regulation FD disclosure. This filing also includes financial statements and exhibits.
Why It Matters
Changes in a company's board and officer appointments can signal shifts in strategic direction or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Board and officer changes can introduce uncertainty regarding future strategy and leadership effectiveness.
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 001-37942 (company_file_number) — SEC File Number
- 30-0645032 (ein) — EIN
- 20251027 (date) — Date of earliest event reported
FAQ
Who are the newly elected directors of CervoMed Inc.?
The filing indicates the election of new directors but does not specify their names in the provided text.
What specific compensatory arrangements were disclosed for the officers?
The filing mentions the disclosure of compensatory arrangements for certain officers, but the details are not provided in the excerpt.
What is the significance of the Regulation FD disclosure?
The Regulation FD disclosure ensures that material non-public information is broadly disseminated to the public, preventing selective disclosure.
What financial statements and exhibits are included with this filing?
The filing states that financial statements and exhibits are included, but their specific content is not detailed in the provided text.
When was CervoMed Inc. incorporated?
CervoMed Inc. was incorporated in Delaware.
Filing Stats: 909 words · 4 min read · ~3 pages · Grade level 9.8 · Accepted 2025-10-29 16:07:06
Key Financial Figures
- $0.001 — on which registered Common Stock , $0.001 par value CRVO NASDAQ Capital Market
- $7 — on grant has an exercise price equal to $7.02, the closing price of the Company's
Filing Documents
- crvo20251029c_8k.htm (8-K) — 30KB
- ex_878763.htm (EX-99.1) — 12KB
- 0001437749-25-032184.txt ( ) — 176KB
- crvo-20251027.xsd (EX-101.SCH) — 3KB
- crvo-20251027_def.xml (EX-101.DEF) — 11KB
- crvo-20251027_lab.xml (EX-101.LAB) — 15KB
- crvo-20251027_pre.xml (EX-101.PRE) — 11KB
- crvo20251029c_8k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On October 28, 2025, the Company issued a press release announcing the appointment of Mr. Quigley as a director. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 7.01 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release, issued October 28, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 29, 2025 CervoMed Inc. By: /s/ William Elder Name: William Elder Title: Chief Financial Officer & General Counsel